semaglutide vs tirzepatide mechanism of action Assessing the Safety and in Black and Asian Populations: A Narrative Review Study reveals distinct mechanisms of

As more data comes out, Im feeling more and more comfortable about the safety argument with these medications

Therefore, Phase 3 trials must confirm efficacy in larger and more diverse populations, define tolerability and discontinuation patterns, identify uncommon safety signals, clarify body-composition outcomes, and test whether combination therapy offers a favorable benefit-risk balance

Chen K, Mu F, Xie J, Kelkar SS, Olivier C, Signorovitch J, et al

[DOI] [PMC free article] [PubMed] [Google Scholar] 75.OGara P.T., Kushner F.G., Ascheim D.D., Casey D.E., Chung M.K., De Lemos J.A., Ettinger S.M., Fang J.C., Fesmire F.M., Franklin B.A., et al

And the data behind it is the same global trial evidence Novo has been collecting for years